Conversion to Aflibercept After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Edema
The study by Rahimy and associates assessed the short-term visual and anatomic outcomes of patients with persistent diabetic macular edema (DME) who were converted from bevacizumab (Avastin; Genentech, Inc, South…